subject area of
- Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea Journal Articles
- Differential Responses of Murine Vaginal and Uterine Epithelial Cells Prior to and Following Herpes Simplex Virus Type 2 (HSV‐2) Infection Journal Articles
- Duration of SARS-CoV-2 shedding: A population-based, Canadian study Journal Articles
- In patients with COVID-19, viral shedding time is 17 d and varies in some subgroups Journal Articles
- Longitudinal Study of Influenza Molecular Viral Shedding in Hutterite Communities Journal Articles
- Maraba virus-vectored cancer vaccines represent a safe and novel therapeutic option for cats Journal Articles
- Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination Journal Articles
- Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial Journal Articles
- Population-level effects of suppressing fever Journal Articles
- Predictors of influenza a molecular viral shedding in Hutterite communities Journal Articles
- Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans Journal Articles
- Prolonged Exposure to Progesterone Prevents Induction of Protective Mucosal Responses following Intravaginal Immunization with Attenuated Herpes Simplex Virus Type 2 Journal Articles
- The impact of syndromic treatment of sexually transmitted diseases on genital shedding of HIV-1 Journal Articles
- The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models Journal Articles
- Vaginal transmission causes prolonged Zika virus shedding in the vaginal mucosa and delays systemic dissemination Journal Articles